Professional Documents
Culture Documents
Abstract
A side effect associated with the use of LSD is the return
of perceptual disturbances which anteriorly emerged
during intoxication, despite absence of present use.
Here we present the case of a patient with a previous
history of sporadic and recreational cannabis, alcohol and
LSD consumption who reported LSD associated Alice
in Wonderland Syndrome (AIWS) or Todds syndrome.
AIWS is basically characterized by four frequent visual
illusions: macropsia, micropsia, pelopsia and teleopsia.
AIWS only appeared during LSD consumption and
continued after LSD suspension, namely, Hallucinogen
Persisting Perception Disorder (HPPD). This phenomenon
did not cause a major functional impairment but provoked
sufficient worry and concern due to its persistent
continuation. The patient refused medical treatment
and continued psychiatric follow-up. At the one year
follow-up he reported complete remission.
To the best of our knowledge this is the first reported case
of AIWS which persist after LSD interruption (HPPD) in
the professional literature. Reasons for this intriguing,
benign, reversible and apparently harmless side effect
are proposed.
Introduction
Alice in Wonderland Syndrome (AIWS) or Todds
syndrome is a condition predominately characterized
for complex perceptual disturbances (1). The name was
Address for Correspondence: Arturo G. Lerner, MD, Lev Hasharon Mental Health Medical Center, POB 90.000, Netanya 42100, Israel
alerner@lev-hasharon.co.il, lerneram@internet-zahav.net
67
References
1. Todd J. The syndrome of Alice in Wonderland. Canadian Med Assoc
J 1955; 73: 701-704.
2. Lewis Carrol. Alices adventures in wonderland. U.K.: Macmillan, 1865.
3. Michelot D, Melendez-Howell LM. Amanita muscaria: Chemistry,
biology, toxicology, and ethnomycology. Mycological Research 2003;
107: 131-146.
4. Losada-Del Pozo R, Cantarn-Extremera V, Garca-Peas JJ, DuatRodrguez A, Lpez-Marn L, Gutirrez-Solana LG, Ruiz-Falc ML.
Characteristics and evolution of patients with Alice in Wonderland
syndrome. Rev Neurol 2011;53:641-648.
5. Lerner AG. Unpublished data.
6. Pacheva IH, Ivanov IS. Migraine variants - occurrence in pediatric
neurology practice. Clin Neurol Neurosur 2013, 115:1775-1783.
7. Bayen E, Cleret de Langavant L, Fnelon G. The Alice in Wonderland
syndrome: An unusual aura in migraine. Rev Neurol 2012; 168:457-459.
8. Kuo SC, Yeh YW, Chen CY, Weng JP, Tzeng NS. Possible association
between Alice in Wonderland syndrome and influenza A infection. J
Neuropsychiatry Clin Neurosci 2012; 24:E7-8.
9. Lahat E, Berkovitch M, Barr J, Paret G, Barzilai A. Abnormal visual
evoked potential in children with Alice in Wonderland syndrome due
to infectious mononucleosis. J Child Neurol 1999; 14: 732-735.
10. Zwijnenburg PJ, Wennink JM, Laman DM, Linssen WH. Alice in
Wonderland syndrome: A clinical presentation of frontal lobe epilepsy.
Neuropediatrics 2002; 33: 53-55.
11. American Psychiatric Association. Diagnostic and Statistical Manual
of Mental Disorders, Fifth Edition, DSM-5. Washington DC: American
Psychiatric Association, 2013.
12. Halpern JH, Pope HG. Hallucinogen persisting perception disorder:
What do we know after 50 years? Drug Alcohol Depend 2003; 69:109-119.
13. Chand PK, Murthy P. Understanding a strange phenomenon: Lilliputian
hallucinations. German J Psychiatry 2007; 10: 21-24.
14. Lorch M. Language and memory disorder in the case of Jonathan Swift:
Considerations on retrospective diagnosis. Brain 2006; 129, 3127-3137.
15. Lerner AG, Gelkopf M, Skladman I, Oyffe I, Finkel B, Sigal M, Weizman
A. Flashback and hallucinogen persisting perception disorder: Clinical
aspects and pharmacological treatment approach. Isr J Psychiatry Relat
Sci 2002, 39: 92-99.
16. Lerner AG, Gelkopf M, Skalman I, Rudinski R, Nachshon H, Bleich
A. Clonazepam treatment of LSD-induced hallucination persisting
perception disorder with anxiety features. Int Clin Psychopharmacol
2003, 18: 101-105.
17. Lerner AG, Rudinski D, Bor O, Goodman C. Flashback and HPPD:
A clinical- oriented concise review. Isr J Psychiatry Relat Sci 2014;
51:296-302.
18. Abraham HD, Aldridge AM, Gogia P. The psychopharmacology of
hallucinogens. Neuropsychopharmacology 1996; 14:285-298.
19. Abraham HD. Visual phenomenology of the LSD flashbacks. Arch Gen
Psychiatry 1983; 40:884-889.
20. Abraham HD, Aldridge AM. Adverse consequences of lysergic acid
diethylamide. Addiction 1993; 88:1327-1334.
21. Evarts EV, Landau W, Freygang W Jr, Marshall WH. Some effects of
lysergic acid diethylamide and bufotenine on electrical activity in the
cats visual system. Am J Physiol 1955; 182:594-598.
22. Bishop PO, Field G, Hennessy BL, Smith JR. Action of d-lysergic acid
diethylamide on lateral geniculate synapses. J Neurophysiol 1958;
21:529-549.
23. Lerner AG, Rudinski D, Goodman C.and Lev Ran S. Flashback and
HPPD: LSD flashbacks The appearance of new visual imagery not
experienced during initial intoxication: Two case reports. Isr J Psychiatry
Relat Sci 2014; 51:307-309.
24. Abe K, Oda N, Araki R, Igata M. Macropsia, micropsia, and episodic
illusions in Japanese adolescents. J Am Acad Child Adolesc Psychiatry
1989; 28:493-496.
25. Schneck JM. Macropsia. Am J Psychiatry 1965; 121:1123-1124.
69